Literature DB >> 11918425

Fresh frozen bone in femoral impaction grafting: can developments in bone regeneration improve on this?

M Heliotis1, E E Tsiridis.   

Abstract

Major advances in the understanding of bone regeneration have led to revolutionary applications of bone conduction and induction. Revision hip surgery is on the increase with an active, ageing population demanding increased quality of life. The technically demanding instrumentation and materials necessary for revision prosthetic hip replacements have been rapidly incorporated into clinical practice. Unfortunately, advantage has not been taken of the basic and fundamental principles of bone induction and regeneration, available for many years now. In impaction grafting for revision hip replacements where fresh frozen bone is currently used as a standard, we argue and demonstrate from the literature why this technique is biologically inferior to the results which potentially can be gained by exploiting osteoinductive grafts such as demineralised bone matrix, hydroxyapetite, and inductive factors such as bone morphogenetic proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11918425     DOI: 10.1054/mehy.2001.1376

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Stability of fused versus nonfused THA femoral impaction grafts.

Authors:  Anneliese D Heiner; John J Callaghan; Thomas D Brown
Journal:  J Orthop Res       Date:  2007-03       Impact factor: 3.494

2.  Stability differentials for proximal vs distal fusion of total hip arthroplasty femoral impaction grafts.

Authors:  Anneliese D Heiner; John J Callaghan; Thomas D Brown
Journal:  J Arthroplasty       Date:  2008-01-24       Impact factor: 4.757

3.  BOVINE LYOPHILIZED GRAFT (BLG): HISTOLOGICAL ANALYSIS ON BEHAVIOR IN HUMANS AFTER 49 MONTHS.

Authors:  Carlos Roberto Galia; Giuseppe De Luca; Luiz Müller Ávila; Ricardo Rosito; Carlos Alberto Souza Macedo
Journal:  Rev Bras Ortop       Date:  2015-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.